Fund Holdings — Springhill Fund Asset Management (HK) Co Ltd

Total Portfolio Value:
$20.87M
Total Bought:
$12.72M
Total Sold:
$53.43M
Net Transaction:
-$40.71M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Verona Pharma PlcADS135,45263,499-71,953$6.29M$4.03M19.32%-$2.26M
Summit Therapeutics Inc.(SMMT)0124,307+124,307$0$2.40M11.49%+$2.40M
Janux Therapeutics, Inc.(JANX)29,60078,500+48,900$1.58M$2.12M10.16%+$534.7K
Regeneron Pharmaceuticals, Inc.(REGN)02,600+2,600$0$1.65M7.90%+$1.65M
Neurocrine Biosciences, Inc.(NBIX)013,612+13,612$0$1.51M7.21%+$1.51M
Insmed Incorporated(INSM)69,50019,192-50,308$4.80M$1.46M7.02%-$3.33M
Soleno Therapeutics Inc1,79319,858+18,065$80.6K$1.42M6.80%+$1.34M
Jazz Pharmaceuticals plcSHS USD(JAZZ)09,853+9,853$0$1.22M5.86%+$1.22M
Akero Therapeutics Inc151,20019,925-131,275$4.21M$806.6K3.87%-$3.40M
argenx SEADR(ARGX)01,146+1,146$0$678.3K3.25%+$678.3K
Eli Lilly and Company(LLY)0816+816$0$673.9K3.23%+$673.9K
Protagonist Therapeutics Inc012,859+12,859$0$621.9K2.98%+$621.9K
TG Therapeutics, Inc.(TGTX)013,500+13,500$0$532.3K2.55%+$532.3K
Tarsus Pharmaceuticals, Inc.(TARS)07,076+7,076$0$363.5K1.74%+$363.5K
Ascendis Pharma A/SADR(ASND)02,173+2,173$0$338.7K1.62%+$338.7K
Rhythm Pharmaceuticals, Inc.(RYTM)06,277+6,277$0$332.5K1.59%+$332.5K
BioNTech SEADS(BNTX)03,000+3,000$0$273.2K1.31%+$273.2K
Springworks Therapeutics Inc05,897+5,897$0$260.2K1.25%+$260.2K
Cogent Biosciences, Inc.(COGT)548,55429,491-519,063$4.28M$176.7K0.85%-$4.10M
ABIVAX Société AnonymeADS(ABVX)207,6000-207,600$1.52M$0—-$1.52M
AstraZeneca PLCADR(AZN)76,5000-76,500$5.01M$0—-$5.01M
Bicycle Therapeutics PlcADS116,4000-116,400$1.63M$0—-$1.63M
Bright Minds Biosciences Inc.(DRUG)60,6480-60,648$2.18M$0—-$2.18M
Cullinan Therapeutics, Inc.(CGEM)276,4000-276,400$3.37M$0—-$3.37M
Cytokinetics, Incorporated(CYTK)130,7350-130,735$6.15M$0—-$6.15M
Dyne Therapeutics, Inc.(DYN)131,2000-131,200$3.09M$0—-$3.09M
Legend Biotech CorporationADS(LEGN)190,8000-190,800$6.21M$0—-$6.21M
Merus N V83,8000-83,800$3.52M$0—-$3.52M
Nurix Therapeutics, Inc.(NRIX)160,5000-160,500$3.02M$0—-$3.02M
Vera Therapeutics, Inc.CL A(VERA)109,4000-109,400$4.63M$0—-$4.63M
Page 1 of 1
Springhill Fund Asset Management (HK) Co Ltd — 13F Holdings — Q1 2025 | TickerTrail